Clinical trial
Methylphenidate in Treating Patients With Melanoma
NCT00003266 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003266 |
|---|---|
| Title | Methylphenidate in Treating Patients With Melanoma |
| Official title | Double-Blind Randomized Trial of Methylphenidate for Alleviation of Fatigue and Lethargy Associated With Interferon Alpha 2b |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fatigue, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Procedure |
| Interventions | methylphenidate hydrochloride, quality-of-life assessment |
| Enrollment | 200 |
| Start date | Oct 12, 1999 |
| Primary completion | May 1, 2002 |
| First posted | Oct 28, 2003 |
| Last update posted | Jun 18, 2023 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: